Free Trial

MarketBeat Instant News Alerts

Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX - Get Free Report) Director Frank Morich purchased 15,000 shares of the firm's stock in a transaction that occurred on Thursday, November 12th. The stock was acquired at an average price of $1.00 per share, with a total value of $15,000.00. Following the completion of the purchase, the director owned 15,000 shares in the company, valued at $15,000. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX - Get Free Report) Director Robert Williamson III bought 18,609 shares of the business's stock in a transaction on Thursday, November 12th. The shares were purchased at an average cost of $0.84 per share, with a total value of $15,631.56. Following the transaction, the director owned 28,473 shares in the company, valued at approximately $23,917.32. The trade was a 188.66% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX - Get Free Report) Director Lori Woods acquired 23,750 shares of Perspective Therapeutics stock in a transaction dated Thursday, November 12th. The shares were bought at an average price of $0.84 per share, for a total transaction of $19,950.00. Following the transaction, the director owned 28,557 shares of the company's stock, valued at approximately $23,987.88. The trade was a 494.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock
Dynex Capital logo with Finance background

Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock

Dynex Capital, Inc. (NYSE:DX - Get Free Report) CEO Smriti Popenoe acquired 2,600 shares of the company's stock in a transaction dated Friday, November 13th. The stock was acquired at an average cost of $9.90 per share, for a total transaction of $25,740.00. Following the completion of the acquisition, the chief executive officer directly owned 543,698 shares in the company, valued at approximately $5,382,610.20. The trade was a 0.48% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

NYSE:DX
Read Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock
Csquare logo with background

Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock

Csquare, Inc. (NYSE:CSQR - Get Free Report) Director Terri Pizzuto bought 2,000 shares of the stock in a transaction dated Friday, November 13th. The shares were acquired at an average price of $16.96 per share, with a total value of $33,920.00. Following the completion of the purchase, the director directly owned 5,600 shares of the company's stock, valued at approximately $94,976. This represents a 55.56% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

NYSE:CSQR
Read Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock
Abeona Therapeutics logo with Healthcare background

Abeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Faith Charles bought 15,000 shares of the business's stock in a transaction on Friday, November 13th. The shares were acquired at an average cost of $2.29 per share, for a total transaction of $34,350.00. Following the purchase, the director directly owned 191,407 shares in the company, valued at $438,322.03. This represents a 8.50% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

NASDAQ:ABEO
Read Abeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company Stock

Trending News

All MarketBeat Instant News Alerts

Dynex Capital logo with Finance background

Dynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 Shares

NYSE:DX
Read Dynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 Shares
Radcom logo with Technology background

Insider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in Stock

NASDAQ:RDCM
Read Insider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in Stock
PureCycle Technologies logo with Materials background

PureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in Stock

NASDAQ:PCT
Read PureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in Stock
Amdocs logo with Technology background

Insider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in Stock

NASDAQ:DOX
Read Insider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in Stock
TriSalus Life Sciences logo with Healthcare background

TriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company Stock

NASDAQ:TLSI
Read TriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company Stock
Donegal Group logo with Finance background

Insider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of Stock

NASDAQ:DGICA
Read Insider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of Stock
CorMedix logo with Healthcare background

CorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 Shares

NASDAQ:CRMD
Read CorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 Shares
ExlService logo with Industrials background

ExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 Shares

NASDAQ:EXLS
Read ExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 Shares
HubSpot logo with Technology background

HubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 Shares

NYSE:HUBS
Read HubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 Shares
Ceva logo with Technology background

Ceva (NASDAQ:CEVA) Raised to Buy at Cfra

NASDAQ:CEVA
Read Ceva (NASDAQ:CEVA) Raised to Buy at Cfra
SolarEdge Technologies logo with Industrials background

SolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & Company

NASDAQ:SEDG
Read SolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & Company
Bullish logo with Finance background

Bullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company

NYSE:BLSH
Read Bullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company
CareTrust REIT logo with Real Estate background

CareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens Jmp

NYSE:CTRE
Read CareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens Jmp
Edwards Lifesciences logo with Healthcare background

Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NYSE:EW
Read Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Haemonetics logo with Healthcare background

Haemonetics (NYSE:HAE) Price Target Raised to $144.00

NYSE:HAE
Read Haemonetics (NYSE:HAE) Price Target Raised to $144.00
SM Energy logo with Energy background

SM Energy (NYSE:SM) Upgraded at Seaport Research Partners

NYSE:SM
Read SM Energy (NYSE:SM) Upgraded at Seaport Research Partners
United Dominion Realty Trust logo with Real Estate background

United Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & Associates

NYSE:UDR
Read United Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & Associates
Henry Schein logo with Healthcare background

Henry Schein (NASDAQ:HSIC) Announces FY 2026 Earnings Guidance

NASDAQ:HSIC
Read Henry Schein (NASDAQ:HSIC) Announces FY 2026 Earnings Guidance
KindlyMD logo with Finance background

KindlyMD (NASDAQ:NAKA) Stock Price Target Lowered at B. Riley Financial

NASDAQ:NAKA
Read KindlyMD (NASDAQ:NAKA) Stock Price Target Lowered at B. Riley Financial
Copart logo with Industrials background

Copart's (CPRT) Equal Weight Rating Reiterated at Stephens

NASDAQ:CPRT
Read Copart's (CPRT) Equal Weight Rating Reiterated at Stephens
Precigen logo with Healthcare background

B. Riley Financial Reaffirms Buy Rating for Precigen (NASDAQ:PGEN)

NASDAQ:PGEN
Read B. Riley Financial Reaffirms Buy Rating for Precigen (NASDAQ:PGEN)
Spectrum Brands logo with Consumer Staples background

Spectrum Brands (NYSE:SPB) Given New $87.00 Price Target at Wells Fargo & Company

NYSE:SPB
Read Spectrum Brands (NYSE:SPB) Given New $87.00 Price Target at Wells Fargo & Company
Codexis logo with Healthcare background

Codexis' (CDXS) "Overweight" Rating Reiterated at Stephens

NASDAQ:CDXS
Read Codexis' (CDXS) "Overweight" Rating Reiterated at Stephens
Hasbro logo with Consumer Discretionary background

Hasbro (NASDAQ:HAS) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NASDAQ:HAS
Read Hasbro (NASDAQ:HAS) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Featured Articles and Offers

Alert Categories

All Alerts